Carregant...

Spotlight on Anti‐CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date

Migraine, a common neurovascular brain disorder, represents a severe and widespread health problem; along with medication‐induced (medication‐overuse) headache, it is the third‐leading cause of disability worldwide. Currently, its therapeutic management remains unsatisfactory for several reasons; up...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Pharmacol Drug Dev
Autors principals: Pellesi, Lanfranco, Guerzoni, Simona, Pini, Luigi Alberto
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5697612/
https://ncbi.nlm.nih.gov/pubmed/28409893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.345
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!